1,2-Pentamethylene-1,4-dihydropyridine derivatives
AssigneeBayer Aktiengesellschaft
InventorsHorst Meyer, Friedrich Bossert, Wulf Vater, Kurt Stoepel
Life of this patent
Estimating the term…
Loading patent…
AssigneeBayer Aktiengesellschaft
InventorsHorst Meyer, Friedrich Bossert, Wulf Vater, Kurt Stoepel
Estimating the term…
1,4-Dihydropyridines bearing carbonyl functions in the 3- and 5-positions, being optionally substituted by lower alkyl in the 6-position, being substituted in the 4-position by lower alkyl, phenyl, substituted phenyl or a heterocyclic group, and being fused through the 1- and 2-positions to a five, six or seven membered cycloalkyl ring, one methylene group of which can be replaced by sulfur, oxygen imino or alkylimino, are anti-hypertensive agents and coronary vessel dilators. The compounds, of which 6-methyl-4-(3-nitrophenyl)-1,2-pentamethylene-1,4-dihydropyridine-3,5-dica rboxylic acid 3,5-diethyl ester is a representative embodiment, are prepared through condensation of an ylideneacetoacetic acid ester and a cyclic enamino carbonyl derivative.
A pharmaceutical composition comprising a compound of the formula:
A pharmaceutical composition comprising a compound of the formula:
A method of producing coronary vessel dilation and an antihypertensive effect in humans and other animals which comprises administering to said human or other animal a compound of the formula:
A method of producing coronary vessel dilation and an antihypertensive effect in humans and other animals which comprises administering to said human or other animal a compound of the formula:
Dependencies are inferred from the claim text.